Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study

Table 3 Risk association between baseline non-HDL-c/HDL-c ratio with GBPs

	Unadjusted	P-value	Model 1^a	P-value	Model 2^b	P-value
	Hazard ratio (95% CI)	P-value	Hazard ratio (95% CI)	P-value	Hazard ratio (95% CI)	P-value
Non-HDL-c/HDL-c ratio	1.29 (1.05, 1.60)	0.0159	1.22 (0.97, 1.54)	0.0932	1.25 (0.96, 1.65)	0.103
Non-HDL-c/HDL-c ratio
0.85–2.03	1		1		1
2.03–2.43	2.62 (1.35, 5.08)	0.0043	2.25 (1.14, 4.43)	0.0187	2.24 (1.13, 4.44)	0.0203
2.43–2.80	1.88 (0.94, 3.75)	0.0739	1.51 (0.74, 3.09)	0.2593	1.50 (0.73, 3.10)	0.269
2.80–3.26	2.84 (1.48, 5.47)	0.0017	2.47 (1.25, 4.85)	0.009	2.52 (1.26, 5.01)	0.0087
3.26–8.79	2.64 (1.37, 5.10)	0.0038	2.16 (1.09, 4.30)	0.0277	2.13 (1.04, 4.37)	0.0397

Data are Hazard ratio (95% CI), P-value, CI confidence interval
GBPs, gallbladder polyps; HDL-c, high-density lipoprotein -cholesterol
^aModel adjusted for age and body mass index
^bModel adjusted for age, body mass index, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, alkaline phosphatase, triglyceride, uric acid, fasting plasma glucose, hepatitis B surface antigen, hypertension, and thickening of the gallbladder wall, smoking and drinking

ISSN: 1476-511X